Alyeska Investment Group
TNDM icon

Alyeska Investment Group’s Tandem Diabetes Care TNDM Stock Holding History

Alyeska Investment Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-900,000
Closed -$4.46M – 524
2018
Q1 		$4.46M Hold
900,000
– – 0.04% 299
2017
Q4 		$2.12M Buy
+900,000
New +$2.83M 0.02% 333

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Alyeska Investment Group's TNDM Position: Q2 2019 in Review

Alyeska Investment Group sold out of Tandem Diabetes Care (TNDM) in Q2 2019, closing a stake of 50,021 shares — an estimated $3.18M sold.

Alyeska Investment Group first reported a position in TNDM in Q1 2017 and held it in 4 quarters. The position peaked at $3.18M in Q1 2019. 261 funds tracked by Wall St. Rank hold TNDM as of Q2 2019.

  • Alyeska Investment Group reported no remaining Tandem Diabetes Care position as of Q2 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 50,021 Tandem Diabetes Care shares in Q2 2019, an estimated $3.18M.
  • Alyeska Investment Group first reported a position in Tandem Diabetes Care in Q1 2017 and held it in 4 quarters.
  • Alyeska Investment Group's Tandem Diabetes Care position peaked at $3.18M in Q1 2019.
  • 261 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2019.

Based on Alyeska Investment Group's 13F filing for Q2 2019, filed 14 Aug 2019.